Effects of sedative doses of propofol, dexmedetomidine, and fentanyl on memory and pain in healthy young adults: A randomized controlled single-blind crossover study using functional magnetic resonance imaging at 7 Tesla.
Keith M Vogt,Marcus A Simmons,Sujatha N Reddy,Alex C Burlew,Courtney N Kozdron,Danielle R Lavage,Sheri Wang,Kane O Pryor,Steven L Shafer,Tamer Ibrahim,Howard J Aizenstein,Lynne M Reder,James W Ibinson,Julie A Fiez
{"title":"Effects of sedative doses of propofol, dexmedetomidine, and fentanyl on memory and pain in healthy young adults: A randomized controlled single-blind crossover study using functional magnetic resonance imaging at 7 Tesla.","authors":"Keith M Vogt,Marcus A Simmons,Sujatha N Reddy,Alex C Burlew,Courtney N Kozdron,Danielle R Lavage,Sheri Wang,Kane O Pryor,Steven L Shafer,Tamer Ibrahim,Howard J Aizenstein,Lynne M Reder,James W Ibinson,Julie A Fiez","doi":"10.1097/aln.0000000000005489","DOIUrl":null,"url":null,"abstract":"BACKGROUND\r\nAnesthetic agents are well known for their effects on memory and pain, however, prior studies quantifying anesthetic-modulation of memory have not included experimental noxious stimulation. This study used functional magnetic resonance imaging (fMRI) to determine how low doses of propofol, dexmedetomidine, and fentanyl affect the brain systems for memory encoding and pain perception.\r\n\r\nMETHODS\r\nThis was a single-blind 1:1:1 randomized placebo-controlled crossover study of 92 healthy volunteers age 18-40. Effect-site concentrations were targeted for propofol (1.0 mcg/ml), dexmedetomidine (0.15 ng/ml), or fentanyl (0.9 ng/ml). Participants listened to a series of 80 words creating a mental picture. Thirty were accompanied by a 2 s painful shock. Blood oxygen-weighted images were obtained at 7 Tesla using a custom head coil. The primary outcome was next-day memory performance, measured by d´, a normalized measure of correct identifications versus false positives. Mixed models were fit to test outcome differences between drug groups. Only statistically significant (p < 0.05) changes are reported, after adjustment for multiple comparisons.\r\n\r\nRESULTS\r\nRecollection, reported as mean d´ (95% confidence interval), was 1.16 (0.97-1.34) under No Drug. This was reduced under propofol 0.51 (0.182-0.842), P=0.006, but not dexmedetomidine 1.04 (0.73-1.35), P=0.99, or fentanyl 0.98 (0.68-1.28), P=0.99. Propofol decreased memory-encoding activation of the hippocampus and amygdala. Propofol reduced pain-related activation in the insula, anterior cingulate, hippocampus, and amygdala. Dexmedetomidine showed decreased memory-related activation in the hippocampus, but did not change pain ratings nor show activation differences in pain-processing areas. Fentanyl showed decreased memory activation in the hippocampus and amygdala. During painful stimulation, fentanyl decreased activation in the primary somatosensory cortex, insula, and increased activation in the anterior cingulate, hippocampus, and amygdala.\r\n\r\nCONCLUSIONS\r\nThese findings add important details to the complex framework of how these distinct anesthetics affect different aspects of cognition through diverse neuroanatomical targets in the brain.","PeriodicalId":7970,"journal":{"name":"Anesthesiology","volume":"4 1","pages":""},"PeriodicalIF":9.1000,"publicationDate":"2025-04-09","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Anesthesiology","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1097/aln.0000000000005489","RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"ANESTHESIOLOGY","Score":null,"Total":0}
引用次数: 0
Abstract
BACKGROUND
Anesthetic agents are well known for their effects on memory and pain, however, prior studies quantifying anesthetic-modulation of memory have not included experimental noxious stimulation. This study used functional magnetic resonance imaging (fMRI) to determine how low doses of propofol, dexmedetomidine, and fentanyl affect the brain systems for memory encoding and pain perception.
METHODS
This was a single-blind 1:1:1 randomized placebo-controlled crossover study of 92 healthy volunteers age 18-40. Effect-site concentrations were targeted for propofol (1.0 mcg/ml), dexmedetomidine (0.15 ng/ml), or fentanyl (0.9 ng/ml). Participants listened to a series of 80 words creating a mental picture. Thirty were accompanied by a 2 s painful shock. Blood oxygen-weighted images were obtained at 7 Tesla using a custom head coil. The primary outcome was next-day memory performance, measured by d´, a normalized measure of correct identifications versus false positives. Mixed models were fit to test outcome differences between drug groups. Only statistically significant (p < 0.05) changes are reported, after adjustment for multiple comparisons.
RESULTS
Recollection, reported as mean d´ (95% confidence interval), was 1.16 (0.97-1.34) under No Drug. This was reduced under propofol 0.51 (0.182-0.842), P=0.006, but not dexmedetomidine 1.04 (0.73-1.35), P=0.99, or fentanyl 0.98 (0.68-1.28), P=0.99. Propofol decreased memory-encoding activation of the hippocampus and amygdala. Propofol reduced pain-related activation in the insula, anterior cingulate, hippocampus, and amygdala. Dexmedetomidine showed decreased memory-related activation in the hippocampus, but did not change pain ratings nor show activation differences in pain-processing areas. Fentanyl showed decreased memory activation in the hippocampus and amygdala. During painful stimulation, fentanyl decreased activation in the primary somatosensory cortex, insula, and increased activation in the anterior cingulate, hippocampus, and amygdala.
CONCLUSIONS
These findings add important details to the complex framework of how these distinct anesthetics affect different aspects of cognition through diverse neuroanatomical targets in the brain.
期刊介绍:
With its establishment in 1940, Anesthesiology has emerged as a prominent leader in the field of anesthesiology, encompassing perioperative, critical care, and pain medicine. As the esteemed journal of the American Society of Anesthesiologists, Anesthesiology operates independently with full editorial freedom. Its distinguished Editorial Board, comprising renowned professionals from across the globe, drives the advancement of the specialty by presenting innovative research through immediate open access to select articles and granting free access to all published articles after a six-month period. Furthermore, Anesthesiology actively promotes groundbreaking studies through an influential press release program. The journal's unwavering commitment lies in the dissemination of exemplary work that enhances clinical practice and revolutionizes the practice of medicine within our discipline.